MyAlcon | India

This page is available in English. Select below for other countries.

MyAlcon | India

This page is available in English. Select below for other countries.



     International - English



     Canada - English / French

     United States - English

Europe / Middle East / Africa
     United Kingdom - English

     Germany - Deutsch

     Switzerland - Deutsch

     Sweden - Swedish

     Norway - Norwegian

     Denmark - Danish

     Finland - Finnish

     Belgium - Nederlands | Français

     Netherlands - Nederlands

Asia Pacific
     India - English

     Japan - Japanese

     Australia - English


Europe / Middle East / Africa


Asia Pacific
     South Korea
     Hong Kong

Ocular Health



Key Benefits


SystaneTM Complete is a lipid based dry eye therapy designed for evaporative dry eye disease


  • Works on lipid layer and muco-aqueous layer of tear film1
  • Increases lipid layer thickness5
  • 97% Patient satisfaction2
Systane COMPLETE pack shot

Features & Technology

  • Works on lipid layer and muco-aqueous layer tear film1
  • Nano-droplet technology enables an increased coverage of the ocular surface with the nano-sized lipid droplets and better stabilization of lipid layer3-4
  • Easy dosing due to the handy Drop-Tainer™ bottle
Features and Technology

Patient Benefits


  • Relieves symptoms of evaporative (lipid deficient) and aquas deficient dry eye
  • Proven patient satisfaction2
Close-up on a woman

1. Silverstein S. et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clinical Ophthalmology 2020:14 3167–3177
2. US EEP Survey; Alcon data on file, 2018
3. Rangarajan R, Ketelson H. Preclinical evaluation of a new hydroxypropyl-guar phospholipid nano emulsion-based artificial tear formulation in models of corneal epithelium. J Oculi Pharmacol Ther. 2019;35(1):32-37
4. Springs CL. Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye. Adv Ther. 2010;27(10):681-690.
5. Weisenberger KR, Fogt JS, Fogt NF. Comparison of Nanoemulsion and Non-Emollient Artificial Tears on Tear Lipid Layer Thickness and Symptoms. J Optom. 2020;S1888-4296(20)30023-6.